Franck X - Search Results

1

In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani.

Nakayama H, Desrivot J, Bories C, Franck X, Figadère B, Hocquemiller R, Fournet A, Loiseau PM. Nakayama H, et al. Among authors: franck x. Biomed Pharmacother. 2007 Feb-Apr;61(2-3):186-8. doi: 10.1016/j.biopha.2007.02.001. Epub 2007 Feb 26. Biomed Pharmacother. 2007. PMID: 17360145

2

Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases.

Nakayama H, Loiseau PM, Bories C, Torres de Ortiz S, Schinini A, Serna E, Rojas de Arias A, Fakhfakh MA, Franck X, Figadère B, Hocquemiller R, Fournet A. Nakayama H, et al. Among authors: franck x. Antimicrob Agents Chemother. 2005 Dec;49(12):4950-6. doi: 10.1128/AAC.49.12.4950-4956.2005. Antimicrob Agents Chemother. 2005. PMID: 16304157 Free PMC article.

3

[Antileishmanial activity of five 2- or 3- quinolines by enyne group].

Seck M, Desrivot J, Bories C, Loiseau P, Franck X, Hocquemiller R, Figadere B, Peyrat JF, Provot O, Brion JD, Alami M. Seck M, et al. Among authors: franck x. Dakar Med. 2006;51(1):1-4. Dakar Med. 2006. PMID: 16924841 French.

4

[Antileishmanial activity of five 2- or 3- quinolines by enyne group].

Seck M, Desrivot J, Bories C, Loiseau P, Franck X, Hocquemiller R, Figadere B, Peyrat JF, Provot O, Brion JD, Alami M. Seck M, et al. Among authors: franck x. Dakar Med. 2005;50(3):172-5. Dakar Med. 2005. PMID: 17633005 French.

5

Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines.

Hui X, Desrivot J, Bories C, Loiseau PM, Franck X, Hocquemiller R, Figadère B. Hui X, et al. Among authors: franck x. Bioorg Med Chem Lett. 2006 Feb 15;16(4):815-20. doi: 10.1016/j.bmcl.2005.11.025. Epub 2005 Nov 23. Bioorg Med Chem Lett. 2006. PMID: 16309903

6

Quinoline compounds decrease in vitro spontaneous proliferation of peripheral blood mononuclear cells (PBMC) from human T-cell lymphotropic virus (HTLV) type-1-infected patients.

Grassi F, Guimarães Corrêa AB, Mascarenhas RE, Galvão B, Séon-Méniel B, Schmidt F, Franck X, Hocquemiller R, Figadère B, Fournet A. Grassi F, et al. Among authors: franck x. Biomed Pharmacother. 2008 Sep;62(7):430-5. doi: 10.1016/j.biopha.2007.05.003. Epub 2007 Jun 6. Biomed Pharmacother. 2008. PMID: 17587535

7

Synthesis and biological evaluation of substituted quinolines: potential treatment of protozoal and retroviral co-infections.

Fakhfakh MA, Fournet A, Prina E, Mouscadet JF, Franck X, Hocquemiller R, Figadère B. Fakhfakh MA, et al. Among authors: franck x. Bioorg Med Chem. 2003 Nov 17;11(23):5013-23. doi: 10.1016/j.bmc.2003.09.007. Bioorg Med Chem. 2003. PMID: 14604664

8

Nematocidal and trichomonacidal activities of 2-substituted quinolines.

Martínez-Grueiro M, Giménez-Pardo C, Gómez-Barrio A, Franck X, Fournet A, Hocquemiller R, Figadère B, Casado-Escribano N. Martínez-Grueiro M, et al. Among authors: franck x. Farmaco. 2005 Mar;60(3):219-24. doi: 10.1016/j.farmac.2004.11.010. Farmaco. 2005. PMID: 15784240

9

Substituted quinolines induce inhibition of proliferation of HTLV-1 infected cells.

Fournet A, Mahieux R, Fakhfakh MA, Franck X, Hocquemiller R, Figadère B. Fournet A, et al. Among authors: franck x. Bioorg Med Chem Lett. 2003 Mar 10;13(5):891-4. doi: 10.1016/s0960-894x(02)01085-5. Bioorg Med Chem Lett. 2003. PMID: 12617915

10

Biological evaluation of substituted quinolines.

Franck X, Fournet A, Prina E, Mahieux R, Hocquemiller R, Figadère B. Franck X, et al. Bioorg Med Chem Lett. 2004 Jul 16;14(14):3635-8. doi: 10.1016/j.bmcl.2004.05.026. Bioorg Med Chem Lett. 2004. PMID: 15203133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters